DD202547A5 - Verfahren zur herstellung von basischen acylamiden von (5-amino-1,3-dialkylpyrazol-4-yl) (aryl)methanonen - Google Patents

Verfahren zur herstellung von basischen acylamiden von (5-amino-1,3-dialkylpyrazol-4-yl) (aryl)methanonen Download PDF

Info

Publication number
DD202547A5
DD202547A5 DD82241009A DD24100982A DD202547A5 DD 202547 A5 DD202547 A5 DD 202547A5 DD 82241009 A DD82241009 A DD 82241009A DD 24100982 A DD24100982 A DD 24100982A DD 202547 A5 DD202547 A5 DD 202547A5
Authority
DD
German Democratic Republic
Prior art keywords
group
compound
carbon atoms
mol
formula
Prior art date
Application number
DD82241009A
Other languages
German (de)
English (en)
Inventor
Horace A Dewald
Lawrence D Wise
David M Lustgarten
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DD202547A5 publication Critical patent/DD202547A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD82241009A 1981-06-26 1982-06-23 Verfahren zur herstellung von basischen acylamiden von (5-amino-1,3-dialkylpyrazol-4-yl) (aryl)methanonen DD202547A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27757781A 1981-06-26 1981-06-26

Publications (1)

Publication Number Publication Date
DD202547A5 true DD202547A5 (de) 1983-09-21

Family

ID=23061477

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82241009A DD202547A5 (de) 1981-06-26 1982-06-23 Verfahren zur herstellung von basischen acylamiden von (5-amino-1,3-dialkylpyrazol-4-yl) (aryl)methanonen

Country Status (11)

Country Link
EP (1) EP0068806A3 (ja)
JP (1) JPS584771A (ja)
AU (1) AU8515182A (ja)
DD (1) DD202547A5 (ja)
DK (1) DK282882A (ja)
ES (3) ES8304550A1 (ja)
FI (1) FI822260L (ja)
GR (1) GR76155B (ja)
IL (1) IL66109A0 (ja)
NO (1) NO822100L (ja)
ZA (1) ZA824468B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208555A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (3-amino-1h-pyrazol-4-yl)-arylmethanone derivatives
DE3600950A1 (de) * 1986-01-15 1987-07-16 Bayer Ag 5-acylamido-1-aryl-pyrazole
FR2665898B1 (fr) * 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558605A (en) * 1969-05-14 1971-01-26 Parke Davis & Co Pyrazolo(3,4-e)(1,4)diazepin-7-(1h)-one compounds
BE735597A (en) * 1969-07-03 1970-01-05 1-aryl 3 4-opt subst 5-aminoalkanoylamino-pyrazoles
FR2100973A1 (en) * 1970-07-30 1972-03-24 Yoshitomi Pharmaceutical 5-Aminopyrazoles - with analgesic, antiinflammatory and muscle relaxant activity
US3886143A (en) * 1974-01-21 1975-05-27 Parke Davis & Co Oxazolo {8 3,2-D{9 pyrazolo{8 4,3-F{9 {0 {8 1,4{9 diazepin-6(7H)-one compounds

Also Published As

Publication number Publication date
ES513399A0 (es) 1983-03-01
FI822260A0 (fi) 1982-06-23
ES8305350A1 (es) 1983-04-01
JPS584771A (ja) 1983-01-11
ES513398A0 (es) 1983-03-01
EP0068806A2 (en) 1983-01-05
ES8304550A1 (es) 1983-03-01
FI822260L (fi) 1982-12-27
GR76155B (ja) 1984-08-03
AU8515182A (en) 1983-01-06
NO822100L (no) 1982-12-27
ES8304551A1 (es) 1983-03-01
ZA824468B (en) 1983-04-27
DK282882A (da) 1982-12-27
ES513375A0 (es) 1983-04-01
IL66109A0 (en) 1982-09-30
EP0068806A3 (en) 1983-08-10

Similar Documents

Publication Publication Date Title
EP0136658B1 (de) 1-Benzyl-aminoalkyl-pyrrolidinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
DE2808067A1 (de) N-(substituierte aminoalkyl)-2-oxo-1- pyrrolidinacetamide und verfahren zu deren herstellung
DE1964516A1 (de) 1-Substituierte 3-Amidopyrrolidine und Verfahren zu ihrer Herstellung
EP0569802A1 (de) Arylacetamide
DE602006000102T2 (de) Indanyl-piperazinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE68922478T2 (de) Pyrazoloisoquinoline-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
CH675418A5 (ja)
EP0023707B1 (de) Substituierte Tetraazatricyclen, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
DD209446A5 (de) Verfahren zur herstellung von neuen aromatischen verbindungen
DE2919800A1 (de) 4-amino-2-piperidinochinazolin-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
DD202547A5 (de) Verfahren zur herstellung von basischen acylamiden von (5-amino-1,3-dialkylpyrazol-4-yl) (aryl)methanonen
CH626058A5 (en) Process for the preparation of basic oxime ethers
DE69014930T2 (de) Aralkylamin-Verbindungen.
DE3025238C2 (ja)
CH678322A5 (ja)
DE3209304C2 (ja)
DD213921A5 (de) Verfahren zur herstellung von substituierten nicotinamid 1-oxyd n- und seinen salzen
DE2840786C2 (ja)
EP0717044A1 (de) Thienopyridonderivate, deren Herstellung und deren Verwendung als NMDA-Rezeptor Antagonisten
DE2609437C2 (ja)
EP0472166A1 (de) Tricyclische Pyridonderivate
DE69307210T2 (de) Cycloalkylalkylamine als Liganden für sigma-Rezeptoren, Verfahren und ihre Herstellung und ihre Anwendung in der Therapie
DE2548668A1 (de) Neue naphthalinverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2526966A1 (de) Tricyclische alkylaminverbindungen, verfahren zu ihrer herstellung und sie enthaltende mittel
EP0212551B1 (de) Neue Tetraoxoverbindungen